Cutaneous localization of angioimmunoblastic T-cell lymphoma may masquerade as B-cell lymphoma or classical Hodgkin lymphoma: A histologic diagnostic pitfall.


Journal

Journal of cutaneous pathology
ISSN: 1600-0560
Titre abrégé: J Cutan Pathol
Pays: United States
ID NLM: 0425124

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 17 05 2018
revised: 12 09 2018
accepted: 22 10 2018
pubmed: 30 10 2018
medline: 11 4 2019
entrez: 30 10 2018
Statut: ppublish

Résumé

We report the cases of three patients presenting skin lesions whose biopsies showed nodular polymorphic infiltrates consisting of lymphocytes, plasma cells, histiocytes, eosinophils, B blasts, and Hodgkin Reed-Sternberg (HRS)-like cells. Two of them were initially diagnosed as classical Hodgkin lymphoma (cHL), on the other hand, the last one as a B-cell lymphoma. All patients have been treated for angioimmunoblastic T-cell lymphoma (AITL). We performed a second review of the skin biopsies with further immunophenotypic molecular analyses. Scrupulous observation revealed, in the background of the three cases, atypical small to medium-sized lymphocytes carrying a CD3+, CD4+ T-cell phenotype and expressing PD1 and CXCL13 follicular helper T-cell markers. The two lesions initially diagnosed as cHL showed scattered HRS-like cells with CD30+, CD15+, PAX5+, CD20-, Epstein Barr Virus (EBV) + classical phenotype. The case initially diagnosed as B-cell lymphoma showed a diffuse B-cell proliferation associated with small B-cell and medium to large-sized B blasts that were positive for EBV. Those cases highlighted that atypical T-cells may be obscured by B-cell proliferation mimicking cHL or B-cell lymphoma in cutaneous localization of AITL and confirmed the requirement of collecting clinical information before performing a diagnosis.

Sections du résumé

BACKGROUND BACKGROUND
We report the cases of three patients presenting skin lesions whose biopsies showed nodular polymorphic infiltrates consisting of lymphocytes, plasma cells, histiocytes, eosinophils, B blasts, and Hodgkin Reed-Sternberg (HRS)-like cells. Two of them were initially diagnosed as classical Hodgkin lymphoma (cHL), on the other hand, the last one as a B-cell lymphoma. All patients have been treated for angioimmunoblastic T-cell lymphoma (AITL).
METHODS METHODS
We performed a second review of the skin biopsies with further immunophenotypic molecular analyses. Scrupulous observation revealed, in the background of the three cases, atypical small to medium-sized lymphocytes carrying a CD3+, CD4+ T-cell phenotype and expressing PD1 and CXCL13 follicular helper T-cell markers. The two lesions initially diagnosed as cHL showed scattered HRS-like cells with CD30+, CD15+, PAX5+, CD20-, Epstein Barr Virus (EBV) + classical phenotype. The case initially diagnosed as B-cell lymphoma showed a diffuse B-cell proliferation associated with small B-cell and medium to large-sized B blasts that were positive for EBV.
CONCLUSION CONCLUSIONS
Those cases highlighted that atypical T-cells may be obscured by B-cell proliferation mimicking cHL or B-cell lymphoma in cutaneous localization of AITL and confirmed the requirement of collecting clinical information before performing a diagnosis.

Identifiants

pubmed: 30370547
doi: 10.1111/cup.13382
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102-110

Informations de copyright

© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Vanessa Szablewski (V)

Département de Biopathologie, CHU Montpellier, Hôpital Gui De Chauliac, Montpellier, France.
Université Montpellier 1, Faculté de Médecine, Montpellier, France.

Olivier Dereure (O)

Université Montpellier 1, Faculté de Médecine, Montpellier, France.
Département de Dermatologie, CHU Montpellier, Hôpital Saint-Eloi, Montpellier.

Céline René (C)

Université Montpellier 1, Faculté de Médecine, Montpellier, France.
Département d'Immunologie, CHU Montpellier, Hôpital Saint Eloi, Montpellier, France.

Ariane Tempier (A)

Département de Biopathologie, CHU Montpellier, Hôpital Gui De Chauliac, Montpellier, France.
Université Montpellier 1, Faculté de Médecine, Montpellier, France.

Luc Durand (L)

Département de Biopathologie, CHU Montpellier, Hôpital Gui De Chauliac, Montpellier, France.
MEDIPATH, Grabels, France.

Melissa Alame (M)

Université Montpellier 1, Faculté de Médecine, Montpellier, France.
Département d'Hématologie Biologique, CHU Montpellier, Hôpital Saint Eloi, Montpellier, France.

Valère Cacheux (V)

Université Montpellier 1, Faculté de Médecine, Montpellier, France.
Département d'Hématologie Biologique, CHU Montpellier, Hôpital Saint Eloi, Montpellier, France.

Valérie Costes-Martineau (V)

Département de Biopathologie, CHU Montpellier, Hôpital Gui De Chauliac, Montpellier, France.
Université Montpellier 1, Faculté de Médecine, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH